bazedoxifene has been researched along with Rhabdomyosarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, Y; Bid, HK; Chen, X; Li, C; Li, H; Lin, J; Wei, J; Wu, X; Xiao, H; Zhao, C | 1 |
1 other study(ies) available for bazedoxifene and Rhabdomyosarcoma
Article | Year |
---|---|
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
Topics: Animals; Cell Line, Tumor; Cytokine Receptor gp130; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |